Belgian start-up IntelliProve raises €1M in Seed funding to further accelerate growth of their video-based health monitoring technology

Insights

IntelliProve’s mission is clear: save human lives by improving health monitoring. The company, led by 4 co-founders, developed a computer technology capable of accurately determining health parameters within a few seconds, based on an optical measurement of the face. A combination of novel signal processing and computer vision technology is at the heart of IntelliProve's technology. Health parameters such as heart rate, blood oxygen saturation, mental biomarkers, respiratory rate and blood pressure are measured using a conventional smartphone camera. Fast, contactless and without the need for specialized equipment or wearables. The IntelliProve technology is the first step towards ‘digital biopsies’, enabling accessible preventive healthcare .

IntelliProve was incorporated in 2021 and is currently in the product testing phase of the software solution. The company recently launched their first product to empower mental health solutions with quantitative biomarker data. IntelliProve will use the funding to further develop their clinically-validated solution, and to accelerate their go-to-market.

Joeri Tulkens, one of the co-founders and CEO of IntelliProve, welcomes the investor backing and says: “This capital injection and trust from our investors shows the importance of our health monitoring solution, which increases the quality and engagement of patient-centered digital healthcare solutions. We’re grateful and humbled to be playing a role in today’s healthcare landscape.”

‍

IntelliProve, an advanced optical health monitoring technology in the palm of your hand

Using a conventional smartphone camera, the IntelliProve’s solution measures physiological and mental health parameters from a face in less than 30 seconds;
IntelliProve is the proud winner of the Belgian eAwards 2022;
IntelliProve is supported by two acceleration programs: Birdhouse and imec.istart;
IntelliProve launched their first product to give mental healthcare platforms the possibility to embed meaningful mental biomarkers and insights into their app/dashboard/platform.

‍

Miles Ahead increases its funding to €30 million to capture the opportunity in the Deep Tech and AI market

The Belgian venture studio and fund has raised an additional 10 million in funding for its Miles Ahead Capital I fund in a final closing round.

Insights

8 min

Tiro.health raises 1 Million to reduce administrative burden of doctors and accelerate the transition to value-based healthcare

Tiro.health, the Ghent-based startup developing software for healthcare professionals announced today that it has successfully completed a capital round of €1 million led by venture studio and fund Miles Ahead, joined by other investors such as Imec.istart and business angel Lorenz Bogaert.

Founder Stories

8 min

The potential of robotics and AI in construction is enormous: tech company AUAR raises 3 million euros.

Startup Automated Architecture (AUAR) has raised £2.6 million in seed capital, a funding round led by the Ghent-based investor Miles Ahead. This funding will be used, among other things, to expand operations in the United States and the United Kingdom.